Featured Research

from universities, journals, and other organizations

Cincinnati Children's Scientists Develop New Spine Staples

Date:
August 11, 2004
Source:
Cincinnati Children's Hospital Medical Center
Summary:
Scientists at Cincinnati Children's Hospital Medical Center have developed a "spine staple" that could eliminate the need for thousands of invasive spine surgeries in children each year.

CINCINNATI — Scientists at Cincinnati Children's Hospital Medical Center have developed a "spine staple" that could eliminate the need for thousands of invasive spine surgeries in children each year.

The spine staple is intended to correct scoliosis, a curvature of the spine. Typically, orthopaedic surgeons track patients as they grow to determine whether the curvature progresses to a point where surgery is necessary. In recent years, however, surgeons have learned to predict rates of curvature progression based on the child's age and the angle of curvature.

The spine staple would be implanted in a minimally invasive procedure in children who are at high risk of needing surgery in adolescence. The staple would slow progression of the curvature or actually decrease the curvature as the child grows.

Cincinnati Children's has signed a license agreement with E-Prime, a Blue Ash, Ohio, company that takes ideas and concepts into product development and clinical trials and prepares them for commercialization. E-Prime will help with advancing development of the staples in collaboration with Cincinnati Children's.

"The spine staple re-directs growth of the spine — slowing growth on the outside of the curve so that the inside can catch up," says Eric Wall, M.D., an orthopaedic surgeon at Cincinnati Children's and co-inventor of the staple. "Surgery will be minimally invasive, safe, relatively simple and at lower cost than current procedures. It will reduce pain and length of hospital stay. And, it will help surgeons, for whom current techniques are like building a ship in a bottle."

Approximately 20,000 children undergo scoliosis surgery each year. The most common form of scoliosis is called idiopathic and usually occurs in otherwise normal children around puberty. Orthopaedists typically recommend braces for spinal curvatures greater than 25-30 degrees and surgical correction for curves greater than 40-50 degrees.

Although current surgical techniques for correction of scoliosis have excellent long-term success rates with few complications, these surgeries involve extensive exposure of the spine, frequent blood transfusions, significant post-operative pain, lengthy hospitalizations and slow rehabilitations. Surgical treatments for adolescents are among the most invasive and expensive. Moreover, standard surgical treatment involves the insertion of rods and a bone graft to fuse the spine into a straightened position.

The spine staple is intended to correct typical scoliosis curvatures. Surgeons will make three or four, one-inch incisions on the side of the body, under the arm. Approximately six spine staples will be inserted through these "portals" and into the spine, across the growth plates. Loss of blood will be minimal, "just drops as opposed to pints," according to Dr. Wall. Rods and spine fusion will be unnecessary.

Dr. Wall developed the spine staples with Donita Bylski-Austrow, Ph.D., an orthopaedic researcher at Cincinnati Children's. A study to determine the staples' safety and effectiveness in children could begin at Cincinnati Children's within the next year.


Story Source:

The above story is based on materials provided by Cincinnati Children's Hospital Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Cincinnati Children's Hospital Medical Center. "Cincinnati Children's Scientists Develop New Spine Staples." ScienceDaily. ScienceDaily, 11 August 2004. <www.sciencedaily.com/releases/2004/08/040811081755.htm>.
Cincinnati Children's Hospital Medical Center. (2004, August 11). Cincinnati Children's Scientists Develop New Spine Staples. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/08/040811081755.htm
Cincinnati Children's Hospital Medical Center. "Cincinnati Children's Scientists Develop New Spine Staples." ScienceDaily. www.sciencedaily.com/releases/2004/08/040811081755.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins